Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.975 USD | +0.31% | -12.24% | -23.13% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.13% | 229M | |
+11.76% | 225B | |
+15.89% | 197B | |
+19.55% | 143B | |
+30.72% | 111B | |
+2.62% | 64.72B | |
+18.96% | 54.44B | |
+4.96% | 51.06B | |
+10.67% | 45.03B | |
+4.98% | 37.4B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Earnings Flash (NPCE) NEUROPACE Posts Q1 Revenue $14.5M, vs. Street Est of $12.2M